Citations 2
Prognostic and predictive significance of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.
Chapman, Judy‐Anne W., Burnell, Margot J., Levine, Mark N. , Whelan, Timothy J. , Albain, Kathy S. , Perez, Edith A. , Virk, Shakeel , O’Brien, Patti, Shepherd, Lois E. , Gelmon, Karen A. , Liu, Shuzhen , Pritchard, Kathleen I. , Rugo, Hope S. , Nielsen, Torsten O.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 11019-11019
Prognostic associations of 25OH vitamin D in NCIC CTG MA.21, a phase III adjuvant RCT of three chemotherapy regimens (EC/T, CEF, AC/T) in high-risk breast cancer (BC).
Chapman, Judy‐Anne W., Burnell, Margot J., Levine, Mark N. , O’Brien, Patti, Han, Lei , Albain, Kathy S. , Perez, Edith A. , Vandenberg, Theodore A. , Chalchal, Haji , Sawhney, Ravinder, Shepherd, Lois E. , Lohmann, Ana Elisa , Tsvetkova, Elena V. , Pritchard, Kathleen I. , Gelmon, Karen A. , Rugo, Hope S. , Goodwin, Pamela J.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 504-504